SQZ Biotechnologies Company

OTCPK:SQZB 株式レポート

時価総額:US$1.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

SQZ Biotechnologies マネジメント

マネジメント 基準チェック /24

SQZ Biotechnologies'の CEO はHoward Bernsteinで、 Nov2022年に任命され、 の在任期間は 1.58年です。 の年間総報酬は$ 1.62Mで、 24.6%給与と75.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.2%を直接所有しており、その価値は$ 2.68K 。経営陣と取締役会の平均在任期間はそれぞれ2.5年と3.7年です。

主要情報

Howard Bernstein

最高経営責任者

US$1.6m

報酬総額

CEO給与比率24.6%
CEO在任期間1.6yrs
CEOの所有権0.2%
経営陣の平均在職期間2.5yrs
取締役会の平均在任期間3.7yrs

経営陣の近況

Recent updates

SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 26
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

Jan 05
We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M

Nov 09

SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology

Oct 20

Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

Aug 20
Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M

Aug 04

SQZ Biotechnologies names business chief as CFO

Jul 11

Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

May 17
Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

May 02
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Jan 11
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Jul 30
Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

May 16
Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

Mar 25
Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 20
SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

Feb 01
We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

CEO報酬分析

SQZ Biotechnologies の収益と比較して、Howard Bernstein の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2023n/an/a

-US$72m

Jun 30 2023n/an/a

-US$71m

Mar 31 2023n/an/a

-US$76m

Dec 31 2022US$2mUS$400k

-US$79m

Sep 30 2022n/an/a

-US$78m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$74m

Dec 31 2021US$1mUS$391k

-US$69m

Sep 30 2021n/an/a

-US$75m

Jun 30 2021n/an/a

-US$64m

Mar 31 2021n/an/a

-US$55m

Dec 31 2020US$750kUS$357k

-US$51m

報酬と市場: Howardの 総報酬 ($USD 1.62M ) は、 US市場 ($USD 667.49K ) の同規模の企業の平均を上回っています。

報酬と収益: Howardの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Howard Bernstein (67 yo)

1.6yrs

在職期間

US$1,624,513

報酬

Dr. Howard Bernstein, M.D., Ph D., had been Chief Scientific Officer of SQZ Biotechnologies Company since June 2015 until October 31, 2022. Dr. Bernstein is Director of SQZ Biotechnologies Company since Oc...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Howard Bernstein
Interim CEO & Director1.6yrsUS$1.62m0.20%
$ 2.7k
Lawrence Knopf
General Counsel & Secretary4.8yrsUS$944.03k0.0066%
$ 87.2
Marshelle Warren
Chief Medical Officer2yrsUS$944.27k0%
$ 0
Robert Langer
Co-Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Richard Capasso
Chief Accounting Officer2.6yrsデータなしデータなし
David First
Chief People Officer4.1yrsデータなしデータなし
Ipsita Roymoulik
Senior Vice President of CMC & QUALITY2.4yrsデータなしデータなし

2.5yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: SQZBの経営陣は 経験豊富 であると考えられます ( 2.5年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Howard Bernstein
Interim CEO & Director1.7yrsUS$1.62m0.20%
$ 2.7k
Robert Langer
Co-Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
David Sachs
Member of Scientific Advisory Boardno dataデータなしデータなし
Amy W. Schulman
Directorno dataUS$104.40k0.74%
$ 9.8k
Patrick V. J. Vink
Independent Director2.9yrsUS$96.62k0%
$ 0
Klavs Jensen
Independent Director11.3yrsUS$89.40k1.15%
$ 15.3k
Bernard Coulie
Independent Chairman2.9yrsUS$94.40k0%
$ 0
Marc Elia
Independent Director6.1yrsUS$86.90k0%
$ 0
Darrell Irvine
Member of Scientific Advisory Boardno dataデータなしデータなし
Pushkal Garg
Independent Director5.8yrsUS$94.40k0%
$ 0
Marc Schegerin
Independent Director3.7yrsUS$94.40k0%
$ 0
Arlene Sharpe
Member of Scientific Advisory Boardno dataデータなしデータなし

3.7yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: SQZBの 取締役会経験豊富 であると考えられます ( 3.7年の平均在任期間)。